Research Topics Safety/Phase I study of PiggyBac transposon mediated Chimeric Antigen Receptor T cells targeting CD-19 in Thai patients with refractory systemic lupus Erythematosus Researchers Wannagam Kijthanamongkolchai Institute Faculty...
Research Topics Expanding Horizons in Immunotherapy: Integrating Advanced Cell Engineering, Reprogramming, and Adjunct Therapies for Cancer and inflammatory-mediated diseases Researchers Prof.Nattiya Hirankarn and TTCI team Institute Faculty of Medicine,...
Event Details I August 16th, 2025 Recorded VDO I August 16th, 2025 (Conference) Recorded VDO I August 16th, 2025 (Conference) Photo I August 16th, 2025 Event Details I August...
We’re excited to announce that we’ll be participating in the Vaccine and Therapeutic RNA Research Forum 2025 on 4 Aug 2025. This is a fantastic opportunity to engage with...
TTCI Researchers Present and Collaborate at the 29th Annual Meeting of the Japanese Association of Cancer Immunology July 26, 2025 TTCI Researchers Present and Collaborate at the 29th Annual...
Researchers from Chulalongkorn University have successfully established a novel human antibody heavy chain variable (VH)-only domain with potent activity against folate receptor alpha-positive solid tumor in CAR-T cell format....
Researchers from Chulalongkorn University have successfully developed MUC1-targeting CAR T cells engineered to secrete an anti-PD-1 antibody, derived from nivolumab, to enhance their effectiveness against solid tumors. These modified...
TTCI Representatives Join World Immunotherapy Council Asia Pacific (WIC APAC 2025) in Singapore July 22, 2025 TTCI Representatives Join World Immunotherapy Council Asia Pacific (WIC APAC 2025) in Singapore...
Special Lecture Announcement The Division of Hematology, Center of Excellence in Translational Hematology, Cellular Immunotherapy Research Unit, Faculty of Medicine, Chulalongkorn University, in collaboration with the Thailand Hub of...
TTCI Welcomes World-Class Expert for Special Lecture and Advisory Role July 4, 2025 On Friday, July 4, 2025, the Division of Hematology, Center of Excellence in Translational Hematology, and...
